United States Biotechnology & Medical Research

LeonaBio Inc (ATHA)

Track

Track

LeonaBio Inc experienced multiple insider trading transactions on March 4, 2026. Key executives, including the CEO, CFO, and Chief Medical Officer, executed sales of company shares. These recent divestments follow similar patterns observed earlier this year. No acquisitions were reported during this period, reflecting a consistent trend of selling activity among leadership members.
Ticker: ATHA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for LeonaBio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.0
Litton Mark James PRESIDENT and CEO Executive Director
Transaction date
Sale
Price
458.68
Quantity 94,883 +18.0%
Value US$1,554,291
3.3
Renninger Robert CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
408.72
Quantity 93,329 -16.4%
Value US$658,119
3.1
Worthington Mark GENERAL COUNSEL and CCO Officer
Transaction date
Sale
Price
147.12
Quantity 84,600 -17.1%
Value US$1,327,675
2.7
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
5.37
Quantity 1,359 -5.1%
Value US$7,298
3.0
San Martin Javier CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.37
Quantity 1,720 -9.8%
Value US$9,236
3.0
Mark James Litton Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.36
Quantity 5,156
Value US$27,662
3.0
Litton Mark James President and CEO Executive Director
Transaction date
Sale
Price
6.88
Quantity 2,586 -6.0%
Value US$17,792
3.3
Renninger Robert Chief Financial Officer Officer
Transaction date
Sale
Price
6.88
Quantity 297 -2.3%
Value US$2,043
3.0
San Martin Javier CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
6.88
Quantity 1,644 -13.9%
Value US$11,311
2.7
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
6.88
Quantity 876 -4.1%
Value US$6,027
3.1
Worthington Mark General Counsel and CCO Officer
Transaction date
Sale
Price
6.88
Quantity 876 -5.9%
Value US$6,027
3.3
Renninger Robert SVP, Finance and Accounting Officer
Transaction date
Sale
Price
0.29
Quantity 2,897 -2.6%
Value US$850
3.1
Worthington Mark General Counsel and CCO Officer
Transaction date
Sale
Price
0.29
Quantity 8,526 -7.1%
Value US$2,502
2.7
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
0.29
Quantity 8,526 -4.8%
Value US$2,502
3.0
Litton Mark James President and CEO Executive Director
Transaction date
Sale
Price
0.29
Quantity 25,123 -7.2%
Value US$7,374
3.0
San Martin Javier CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
0.29
Quantity 10,842 -13.1%
Value US$3,182
3.0
Mark James Litton Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.29
Quantity 25,123
Value US$7,374
3.0
Javier San Martin Officer Officer
Transaction date
Proposed sale
Price
0.29
Quantity 10,842
Value US$3,182
2.7
Kevin Church Officer Officer
Transaction date
Proposed sale
Price
0.29
Quantity 8,526
Value US$2,502
3.1
Mark Worthington Officer Officer
Transaction date
Proposed sale
Price
0.29
Quantity 8,526
Value US$2,502
3.0
San Martin Javier CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
0.56
Quantity 10,826 -23.2%
Value US$6,083
3.1
Worthington Mark General Counsel and CCO Officer
Transaction date
Sale
Price
0.56
Quantity 8,510 -9.2%
Value US$4,782
3.3
Renninger Robert VP of Finance Officer
Transaction date
Sale
Price
0.56
Quantity 2,881 -3.1%
Value US$1,619
3.0
Litton Mark James President and CEO Executive Director
Transaction date
Sale
Price
0.56
Quantity 25,107 -9.4%
Value US$14,108
2.7
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
0.56
Quantity 8,510 -6.1%
Value US$4,782
3.0
Javier San Martin Officer Officer
Transaction date
Proposed sale
Price
0.56
Quantity 10,826
Value US$6,083
3.0
Mark James Litton Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.56
Quantity 25,107
Value US$14,108
3.1
Mark Worthington Officer Officer
Transaction date
Proposed sale
Price
0.56
Quantity 8,510
Value US$4,782
2.7
Kevin Church Officer Officer
Transaction date
Proposed sale
Price
0.56
Quantity 8,510
Value US$4,782
3.0
Mark James Litton Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.00
Quantity 5,032
Value US$1
2.0
Lenington Rachel COO and CDO Officer
Transaction date
Sale
Price
0.57
Quantity 2,525 -10.8%
Value US$1,429
3.1
Worthington Mark GENERAL COUNSEL Officer
Transaction date
Sale
Price
0.57
Quantity 2,525 -4.6%
Value US$1,429
2.7
CHURCH KEVIN CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
0.57
Quantity 2,525 -2.7%
Value US$1,429
1.8
Gengos Andrew CFO and Chief Business Officer Officer
Transaction date
Sale
Price
0.57
Quantity 1,272 -1.3%
Value US$720
3.0
Litton Mark James President and CEO Executive Director
Transaction date
Sale
Price
0.57
Quantity 5,032 -3.1%
Value US$2,848
2.1
Romano Kelly A Non-Executive Director
Transaction date
Purchase
Price
2.42
Quantity 27,400 +51.4%
Value US$66,179
2.1
Romano Kelly A Non-Executive Director
Transaction date
Purchase
Price
2.26
Quantity 15,000 +39.1%
Value US$33,872
2.0
Lenington Rachel Chief Operating Officer Officer
Transaction date
Sale
Price
2.91
Quantity 2,412 -15.3%
Value US$7,019
3.1
Worthington Mark General Counsel Officer
Transaction date
Sale
Price
2.91
Quantity 2,412 -6.5%
Value US$7,019
3.0
Litton Mark James Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.91
Quantity 4,820 -3.2%
Value US$14,026
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.38
Quantity 163,954 +3.1%
Value US$390,211
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.44
Quantity 409,598 +8.5%
Value US$999,419
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.28
Quantity 32,134 +0.7%
Value US$73,266
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.44
Quantity 11,719 +17.2%
Value US$40,308
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.40
Quantity 2,859 +4.4%
Value US$9,721
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.36
Quantity 422 +0.6%
Value US$1,417
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.02
Quantity 10,000 +18.2%
Value US$30,154
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.00
Quantity 10,000 +22.2%
Value US$29,999
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.00
Quantity 10,000 +28.6%
Value US$29,997
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
3.00
Quantity 15,000 +75.0%
Value US$45,000
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
2.95
Quantity 3,418 +20.6%
Value US$10,066
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
2.86
Quantity 6,582 +65.7%
Value US$18,823
1.8
Gengos Andrew See Below Officer
Transaction date
Purchase
Price
2.75
Quantity 10,012 +inf%
Value US$27,533
3.1
JOHNSON JAMES A Non-Executive Director
Transaction date
Purchase
Price
2.40
Quantity 5,000 +inf%
Value US$12,000
1.8
Gengos Andrew See Below Officer
Transaction date
Sale
Price
2.91
Quantity 1,208 -1.4%
Value US$3,515
2.7
CHURCH KEVIN Chief Scientific Officer Officer
Transaction date
Sale
Price
2.91
Quantity 2,412 -2.9%
Value US$7,019
2.1
MILESON GLENNA Chief Financial Officer Officer
Transaction date
Purchase
Price
2.85
Quantity 50,000 +45.5%
Value US$142,250
2.1
Romano Kelly A Non-Executive Director
Transaction date
Purchase
Price
3.29
Quantity 30,000 +360.8%
Value US$98,700
1.4
MOEBIUS HANS Chief Medical Officer Officer
Transaction date
Purchase
Price
3.29
Quantity 5,000 +8.2%
Value US$16,442
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.99
Quantity 1,101,362 +29.8%
Value US$3,293,072
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
2.99
Quantity 270,000 +7.9%
Value US$807,300
3.1
Worthington Mark General Counsel Officer
Transaction date
Sale
Price
2.69
Quantity 2,614 -12.0%
Value US$7,032
2.0
Lenington Rachel Chief Operating Officer Officer
Transaction date
Sale
Price
2.69
Quantity 4,193 -41.9%
Value US$11,279
3.0
Litton Mark James Chief Executive Officer Executive Director
Transaction date
Sale
Price
2.69
Quantity 7,960 -5.8%
Value US$21,412
2.1
MILESON GLENNA Chief Financial Officer Officer
Transaction date
Sale
Price
2.69
Quantity 2,614 -2.3%
Value US$7,032
2.7
CHURCH KEVIN Executive VP, Research Officer
Transaction date
Sale
Price
2.69
Quantity 2,614 -4.3%
Value US$7,032
2.1
Romano Kelly A Non-Executive Director
Transaction date
Purchase
Price
13.11
Quantity 8,000 +2539.7%
Value US$104,880
2.7
PERCEPTIVE ADVISORS LLC Non-Executive Director Large shareholder
Transaction date
Purchase
Price
22.50
Quantity 311,111 +10.0%
Value US$6,999,998
3.9
EDELMAN JOSEPH Non-Executive Director Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 1,058,824 +51.5%
Value US$18,000,008
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 1,058,824 +51.5%
Value US$18,000,008
2.7
RTW INVESTMENTS, LP Large shareholder
Transaction date
Purchase
Price
17.00
Quantity 750,000 +39.1%
Value US$12,750,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-05 2026-03-04 S Sale
3.0
Litton Mark James

PRESIDENT and CEO

Executive Director
94,883 +18.0%
458.68
US$1,554,291 		94,883 +18.0% 458.68 US$1,554,291
2026-03-05 2026-03-04 S Sale
3.3
Renninger Robert

CHIEF FINANCIAL OFFICER

Officer
93,329 -16.4%
408.72
US$658,119 		93,329 -16.4% 408.72 US$658,119
2026-03-05 2026-03-04 S Sale
3.1
Worthington Mark

GENERAL COUNSEL and CCO

Officer
84,600 -17.1%
147.12
US$1,327,675 		84,600 -17.1% 147.12 US$1,327,675
2026-03-05 2026-03-04 S Sale
2.7
CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

Officer
1,359 -5.1%
5.37
US$7,298 		1,359 -5.1% 5.37 US$7,298
2026-03-05 2026-03-04 S Sale
3.0
San Martin Javier

CHIEF MEDICAL OFFICER

Officer
1,720 -9.8%
5.37
US$9,236 		1,720 -9.8% 5.37 US$9,236
2026-03-04 2026-03-04 PrS Proposed sale
3.0
Mark James Litton

Officer; Director

Executive Director
5,156
5.36
US$27,662 		5,156 5.36 US$27,662
2026-01-05 2026-01-02 S Sale
3.0
Litton Mark James

President and CEO

Executive Director
2,586 -6.0%
6.88
US$17,792 		2,586 -6.0% 6.88 US$17,792
2026-01-05 2026-01-02 S Sale
3.3
Renninger Robert

Chief Financial Officer

Officer
297 -2.3%
6.88
US$2,043 		297 -2.3% 6.88 US$2,043
2026-01-05 2026-01-02 S Sale
3.0
San Martin Javier

CHIEF MEDICAL OFFICER

Officer
1,644 -13.9%
6.88
US$11,311 		1,644 -13.9% 6.88 US$11,311
2026-01-05 2026-01-02 S Sale
2.7
CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

Officer
876 -4.1%
6.88
US$6,027 		876 -4.1% 6.88 US$6,027
2026-01-05 2026-01-02 S Sale
3.1
Worthington Mark

General Counsel and CCO

Officer
876 -5.9%
6.88
US$6,027 		876 -5.9% 6.88 US$6,027
2025-07-02 2025-07-01 S Sale
3.3
Renninger Robert

SVP, Finance and Accounting

Officer
2,897 -2.6%
0.29
US$850 		2,897 -2.6% 0.29 US$850
2025-07-02 2025-07-01 S Sale
3.1
Worthington Mark

General Counsel and CCO

Officer
8,526 -7.1%
0.29
US$2,502 		8,526 -7.1% 0.29 US$2,502
2025-07-02 2025-07-01 S Sale
2.7
CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

Officer
8,526 -4.8%
0.29
US$2,502 		8,526 -4.8% 0.29 US$2,502
2025-07-02 2025-07-01 S Sale
3.0
Litton Mark James

President and CEO

Executive Director
25,123 -7.2%
0.29
US$7,374 		25,123 -7.2% 0.29 US$7,374
2025-07-02 2025-07-01 S Sale
3.0
San Martin Javier

CHIEF MEDICAL OFFICER

Officer
10,842 -13.1%
0.29
US$3,182 		10,842 -13.1% 0.29 US$3,182
2025-07-01 2025-07-01 PrS Proposed sale
3.0
Mark James Litton

Officer; Director

Executive Director
25,123
0.29
US$7,374 		25,123 0.29 US$7,374
2025-07-01 2025-07-01 PrS Proposed sale
3.0
Javier San Martin

Officer

Officer
10,842
0.29
US$3,182 		10,842 0.29 US$3,182
2025-07-01 2025-07-01 PrS Proposed sale
2.7
Kevin Church

Officer

Officer
8,526
0.29
US$2,502 		8,526 0.29 US$2,502
2025-07-01 2025-07-01 PrS Proposed sale
3.1
Mark Worthington

Officer

Officer
8,526
0.29
US$2,502 		8,526 0.29 US$2,502
2025-01-03 2025-01-02 S Sale
3.0
San Martin Javier

CHIEF MEDICAL OFFICER

Officer
10,826 -23.2%
0.56
US$6,083 		10,826 -23.2% 0.56 US$6,083
2025-01-03 2025-01-02 S Sale
3.1
Worthington Mark

General Counsel and CCO

Officer
8,510 -9.2%
0.56
US$4,782 		8,510 -9.2% 0.56 US$4,782
2025-01-03 2025-01-02 S Sale
3.3
Renninger Robert

VP of Finance

Officer
2,881 -3.1%
0.56
US$1,619 		2,881 -3.1% 0.56 US$1,619
2025-01-03 2025-01-02 S Sale
3.0
Litton Mark James

President and CEO

Executive Director
25,107 -9.4%
0.56
US$14,108 		25,107 -9.4% 0.56 US$14,108
2025-01-03 2025-01-02 S Sale
2.7
CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

Officer
8,510 -6.1%
0.56
US$4,782 		8,510 -6.1% 0.56 US$4,782
2025-01-02 2025-01-02 PrS Proposed sale
3.0
Javier San Martin

Officer

Officer
10,826
0.56
US$6,083 		10,826 0.56 US$6,083
2025-01-02 2025-01-02 PrS Proposed sale
3.0
Mark James Litton

Officer; Director

Executive Director
25,107
0.56
US$14,108 		25,107 0.56 US$14,108
2025-01-02 2025-01-02 PrS Proposed sale
3.1
Mark Worthington

Officer

Officer
8,510
0.56
US$4,782 		8,510 0.56 US$4,782
2025-01-02 2025-01-02 PrS Proposed sale
2.7
Kevin Church

Officer

Officer
8,510
0.56
US$4,782 		8,510 0.56 US$4,782
2024-09-05 2024-09-05 PrS Proposed sale
3.0
Mark James Litton

Officer; Director

Executive Director
5,032
0.00
US$1 		5,032 0.00 US$1
2024-09-05 2024-09-05 S Sale
2.0
Lenington Rachel

COO and CDO

Officer
2,525 -10.8%
0.57
US$1,429 		2,525 -10.8% 0.57 US$1,429
2024-09-05 2024-09-05 S Sale
3.1
Worthington Mark

GENERAL COUNSEL

Officer
2,525 -4.6%
0.57
US$1,429 		2,525 -4.6% 0.57 US$1,429
2024-09-05 2024-09-05 S Sale
2.7
CHURCH KEVIN

CHIEF SCIENTIFIC OFFICER

Officer
2,525 -2.7%
0.57
US$1,429 		2,525 -2.7% 0.57 US$1,429
2024-09-05 2024-09-05 S Sale
1.8
Gengos Andrew

CFO and Chief Business Officer

Officer
1,272 -1.3%
0.57
US$720 		1,272 -1.3% 0.57 US$720
2024-09-05 2024-09-05 S Sale
3.0
Litton Mark James

President and CEO

Executive Director
5,032 -3.1%
0.57
US$2,848 		5,032 -3.1% 0.57 US$2,848
2024-06-25 2024-06-24 B Purchase
2.1
Romano Kelly A
Non-Executive Director
27,400 +51.4%
2.42
US$66,179 		27,400 +51.4% 2.42 US$66,179
2024-06-25 2024-06-21 B Purchase
2.1
Romano Kelly A
Non-Executive Director
15,000 +39.1%
2.26
US$33,872 		15,000 +39.1% 2.26 US$33,872
2024-01-08 2024-01-05 S Sale
2.0
Lenington Rachel

Chief Operating Officer

Officer
2,412 -15.3%
2.91
US$7,019 		2,412 -15.3% 2.91 US$7,019
2024-01-08 2024-01-05 S Sale
3.1
Worthington Mark

General Counsel

Officer
2,412 -6.5%
2.91
US$7,019 		2,412 -6.5% 2.91 US$7,019
2024-01-08 2024-01-05 S Sale
3.0
Litton Mark James

Chief Executive Officer

Executive Director
4,820 -3.2%
2.91
US$14,026 		4,820 -3.2% 2.91 US$14,026
2023-12-29 2023-12-29 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
163,954 +3.1%
2.38
US$390,211 		163,954 +3.1% 2.38 US$390,211
2023-12-29 2023-12-28 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
409,598 +8.5%
2.44
US$999,419 		409,598 +8.5% 2.44 US$999,419
2023-12-29 2023-12-27 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
32,134 +0.7%
2.28
US$73,266 		32,134 +0.7% 2.28 US$73,266
2023-06-09 2023-06-07 B Purchase
1.8
Gengos Andrew

See Below

Officer
11,719 +17.2%
3.44
US$40,308 		11,719 +17.2% 3.44 US$40,308
2023-06-09 2023-06-07 B Purchase
1.8
Gengos Andrew

See Below

Officer
2,859 +4.4%
3.40
US$9,721 		2,859 +4.4% 3.40 US$9,721
2023-06-09 2023-06-07 B Purchase
1.8
Gengos Andrew

See Below

Officer
422 +0.6%
3.36
US$1,417 		422 +0.6% 3.36 US$1,417
2023-06-06 2023-06-05 B Purchase
1.8
Gengos Andrew

See Below

Officer
10,000 +18.2%
3.02
US$30,154 		10,000 +18.2% 3.02 US$30,154
2023-06-06 2023-06-05 B Purchase
1.8
Gengos Andrew

See Below

Officer
10,000 +22.2%
3.00
US$29,999 		10,000 +22.2% 3.00 US$29,999
2023-06-06 2023-06-05 B Purchase
1.8
Gengos Andrew

See Below

Officer
10,000 +28.6%
3.00
US$29,997 		10,000 +28.6% 3.00 US$29,997
2023-06-06 2023-06-05 B Purchase
1.8
Gengos Andrew

See Below

Officer
15,000 +75.0%
3.00
US$45,000 		15,000 +75.0% 3.00 US$45,000
2023-06-06 2023-06-02 B Purchase
1.8
Gengos Andrew

See Below

Officer
3,418 +20.6%
2.95
US$10,066 		3,418 +20.6% 2.95 US$10,066
2023-06-06 2023-06-02 B Purchase
1.8
Gengos Andrew

See Below

Officer
6,582 +65.7%
2.86
US$18,823 		6,582 +65.7% 2.86 US$18,823
2023-06-06 2023-06-02 B Purchase
1.8
Gengos Andrew

See Below

Officer
10,012 +inf%
2.75
US$27,533 		10,012 +inf% 2.75 US$27,533
2023-03-30 2023-03-29 B Purchase
3.1
JOHNSON JAMES A
Non-Executive Director
5,000 +inf%
2.40
US$12,000 		5,000 +inf% 2.40 US$12,000
2024-01-08 2023-01-05 S Sale
1.8
Gengos Andrew

See Below

Officer
1,208 -1.4%
2.91
US$3,515 		1,208 -1.4% 2.91 US$3,515
2024-01-08 2023-01-05 S Sale
2.7
CHURCH KEVIN

Chief Scientific Officer

Officer
2,412 -2.9%
2.91
US$7,019 		2,412 -2.9% 2.91 US$7,019
2022-12-30 2022-12-28 B Purchase
2.1
MILESON GLENNA

Chief Financial Officer

Officer
50,000 +45.5%
2.85
US$142,250 		50,000 +45.5% 2.85 US$142,250
2022-12-06 2022-12-02 B Purchase
2.1
Romano Kelly A
Non-Executive Director
30,000 +360.8%
3.29
US$98,700 		30,000 +360.8% 3.29 US$98,700
2022-11-17 2022-11-15 B Purchase
1.4
MOEBIUS HANS

Chief Medical Officer

Officer
5,000 +8.2%
3.29
US$16,442 		5,000 +8.2% 3.29 US$16,442
2022-07-01 2022-06-30 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
1,101,362 +29.8%
2.99
US$3,293,072 		1,101,362 +29.8% 2.99 US$3,293,072
2022-07-01 2022-06-29 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
270,000 +7.9%
2.99
US$807,300 		270,000 +7.9% 2.99 US$807,300
2022-06-24 2022-06-23 S Sale
3.1
Worthington Mark

General Counsel

Officer
2,614 -12.0%
2.69
US$7,032 		2,614 -12.0% 2.69 US$7,032
2022-06-24 2022-06-23 S Sale
2.0
Lenington Rachel

Chief Operating Officer

Officer
4,193 -41.9%
2.69
US$11,279 		4,193 -41.9% 2.69 US$11,279
2022-06-24 2022-06-23 S Sale
3.0
Litton Mark James

Chief Executive Officer

Executive Director
7,960 -5.8%
2.69
US$21,412 		7,960 -5.8% 2.69 US$21,412
2022-06-24 2022-06-23 S Sale
2.1
MILESON GLENNA

Chief Financial Officer

Officer
2,614 -2.3%
2.69
US$7,032 		2,614 -2.3% 2.69 US$7,032
2022-06-24 2022-06-23 S Sale
2.7
CHURCH KEVIN

Executive VP, Research

Officer
2,614 -4.3%
2.69
US$7,032 		2,614 -4.3% 2.69 US$7,032
2022-04-01 2022-03-31 B Purchase
2.1
Romano Kelly A
Non-Executive Director
8,000 +2539.7%
13.11
US$104,880 		8,000 +2539.7% 13.11 US$104,880
2021-01-27 2021-01-25 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Non-Executive Director Large shareholder
311,111 +10.0%
22.50
US$6,999,998 		311,111 +10.0% 22.50 US$6,999,998
2020-09-22 2020-09-22 B Purchase
3.9
EDELMAN JOSEPH
Non-Executive Director Large shareholder
1,058,824 +51.5%
17.00
US$18,000,008 		1,058,824 +51.5% 17.00 US$18,000,008
2020-09-22 2020-09-22 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
1,058,824 +51.5%
17.00
US$18,000,008 		1,058,824 +51.5% 17.00 US$18,000,008
2020-09-22 2020-09-18 B Purchase
2.7
RTW INVESTMENTS, LP
Large shareholder
750,000 +39.1%
17.00
US$12,750,000 		750,000 +39.1% 17.00 US$12,750,000
Explore more

More insider trading research around LeonaBio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America